Anixa Biosciences Inc
ANIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000715446
In the last 90 days, Anixa Biosciences Inc insiders filed 15 open-market purchases and 0 sales; 63 institutions reported holding it in 13F filings for Q2 2026, worth $15.0M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Anixa Biosciences Inc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 32 | 35 | +3 |
| Shares | 2.95M | 3.18M | +225.7K (+7.6%) |
| Value | $11.5M | $15.2M | +$3.70M (+32.3%) |
New holders (7)
Institutions that held Anixa Biosciences Inc at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 41,973 | $200.0K | 0.00% |
| Wealth Alliance Advisory Group, LLC | 16,413 | $78.0K | 0.04% |
| Citadel Advisors LLC | 14,258 | $68.0K | 0.00% |
| Virtu Financial LLC | 11,794 | $56.0K | 0.00% |
| Cedar Brook Financial Partners, LLC | 10,000 | $48.0K | 0.01% |
| Adirondack Trust Co | 7,000 | $33.0K | 0.02% |
| Tradition Wealth Management, LLC | 1,000 | $5.00K | 0.00% |
Sold out (4)
Institutions that held Anixa Biosciences Inc at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Stifel Financial Corp | 20,000 | $78.0K |
| Barclays PLC | 2,532 | $10.0K |
| Accel Wealth Management | 1,250 | $5.00K |
| Advisory Services Network, LLC | 400 | $2.00K |